CN1062172C - Medicine for treating cervical spondylopathy - Google Patents
Medicine for treating cervical spondylopathy Download PDFInfo
- Publication number
- CN1062172C CN1062172C CN97109245A CN97109245A CN1062172C CN 1062172 C CN1062172 C CN 1062172C CN 97109245 A CN97109245 A CN 97109245A CN 97109245 A CN97109245 A CN 97109245A CN 1062172 C CN1062172 C CN 1062172C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- root
- disease
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating cervical vertebra disease. The formula of the medicine comprises: 2 to 3% of gecko, 0.8 to 2% of sea horse, 3 to 5% of antler, 3 to 5% of terrapin shell, 3 to 5% of turtle shell, 3 to 5% of lily bulb, 3 to 5% of radix adenophorae, 3 to 5% of ophiopogon root, 3 to 5% of white peony root, 3 to 5% of Chinese magnoliavine fruit, 0.8 to 2% of sun-dried ginseng, 3 to 5% of raw astragalus root, 3 to 5% of cortex moutan, 3 to 5% of red peony root, 8 to 10% of long-noded pit viper, 2 to 4% of centipede, 0.8 to 2% of scorpion, 0.8 to 2% of stiff silkworm, 0.8 to 2% of aulastomum gulo, 1 to 3% of notopterygium root, 0.8 to 2% of ground beetle, 0.8 to 2% of bile arisaema, 1 to 3% of prepared common monkshood mother root, 1 to 3% of kusnezoff monkshood root, 1 to 3% of raw curare, 1 to 3% of kudzuvine root, 0.8 to 2% of ligusticum, 0.8 to 2% of Chinese azalea flower and immature bitter orange as the rest. The medicine of the present invention has the advantage that patients are fundamentally treated by prescribing specific medicine for a disease from the disease cause basic theory of the patients and utilizing Chinese herbal medicines, and the medicine of the present invention improves the integrated capability of human bodies and activity of human bodies and is matched with massage to cause cervical spondylosis patients to recover and cure; simultaneously, the medicine has no toxin and no side effect.
Description
The present invention relates to medical technical field, specifically a kind of pharmaceutical formulation for the treatment of cervical spondylosis.
The medicine of treatment cervical spondylosis is a lot of on the market now, is Western medicine at most, can only reduce patient's pain, does not suit the remedy to the case from patient's cause of disease base reason, and institute's therapeutic effect is all poor.Be difficult to remove patient's misery.
The objective of the invention is from the Ji Li of cervical spondylosis morbidity, with the unique curative effect allotment of the Chinese herbal medicine of China prescription, radical cure cervical spondylosis.
The pharmaceutical formulation that the present invention treats cervical spondylosis is according to the modal cervical spondylosis of people spondylotic radiculopathy and cervical vertebra tremulous pulse type to be arranged.The former sees headache more, disease of hand pain and amyotrophy.The latter is common dizzy, feel sick tending to vomit, visual disorder and mental symptom.Adrenergic type also belongs to clinical common type, and main performance influences blood pressure, arrhythmia, and the face symptom, frequent micturition, precordialgia also often merges coronary heart disease.Above etiology and pathology is from the part, and often by the cervical region chronic strain, wind-cold damp pathogen is invaded outward and the head bruise, causes cervical vertebra B﹠J blood supply insufficiency, and degeneration takes place.From integral body, be deficiency of the liver and kindey, essence and blood loses empty, the muscles and bones joint lose moisten and hematogenous blockage due to, regulate disorderly in close relations with human nerve body fluid.
In the clinical practice of treatment cervical spondylosis, realize, the generation of cervical spondylosis, development and transformation, although in close relations with neck bone and muscle ligament pathological changes thereof, relevant with local rheumatism strain,, the prior degeneration and weakness that still is the inherent function of human body.In through saying: " in healthy energy deposited, heresy can not be done, heresy gather, its gas must void." cervical spondylosis is to take place on the basis of human body weakness and development.
With regard to Chinese medicine, the degeneration of function of human body is with weak.Mainly show the liver of human body, above the deficiency of the kidney void.Many person in middle and old age's property illness all are to take place on the advance and retreat basis of caused by liver and kidney deficiency, and development and variation as common coronary heart disease, hypertension, diabetes etc.Cervical spondylosis is also as the same.
With regard to human anatomy, the hyperosteogeny of cervical vertebra is the degenerative change on the Human Physiology, be body in order to compensate the wearing and tearing of vertebra, safeguard a kind of self-protection measure that spinal column mechanical balance is adopted.Therefore, hyperosteogeny is can not cause symptom in most cases.
Based on above analysis, the spy joins following percentage by weight and counts raw material from base reason radical cure cervical spondylosis.Gecko: 2-3%; Hippocampus: 0.8-2%; Cornu Cervi: 3-5%; Carapax et Plastrum Testudinis: 3-5%; Carapax Trionycis: 3-5%; Bulbus Lilii: 3-5%; Radix Adenophorae (Radix Glehniae): 3-5%; Radix Ophiopogonis: 3-5%; The Radix Paeoniae Alba: 3-5%; Fructus Schisandrae Chinensis: 3-5%; Radix Ginseng: 0.8-2%; Radix Astragali: 3-5%; Cortex Moutan: 3-5%; Radix Paeoniae Rubra: 3-5%; Agkistrodon: 8-10%; Scolopendra: 2-4%; Scorpio: 0.8-2%; Bombyx Batryticatus: 0.8-2%: Hirudo: 0.8-2%; Rhizoma Et Radix Notopterygii: 1-3%; worm: 0.8-2%; Arisaema Cum Bile: 0.8-2%; Radix Aconiti Preparata: 1-3%; Radix Aconiti Kusnezoffii: 1-3%; Semen Strychni: 1-3%; Radix Puerariae: 1-3%; Rhizoma Ligustici: 0.8-2%; Flos Rhododendri Mollis: 0.8-2%; The Fructus Aurantii Immaturus remainder.
The different accessory drugss that add of kind of suffering from cervical spondylosis according to patient.Nerve root cervical spondylosis class:
Radix Et Rhizoma Rhei: 1-3%; Radix Gentianae: 3-4%; Radix Scutellariae: 3-4%.Arterial root cervical spondylosis class:
Pericarpium Citri Reticulatae: 2-4%; Radix Bupleuri: 1-2%; Concha Haliotidis: 2-4%; SHENGLONGMU: 2-4%;
Radix Achyranthis Bidentatae: 1-2%; Herba Pogostemonis: 2-4%.
The advantage that the present invention treats the Chinese medicine preparation of cervical spondylosis is to suit the remedy to the case from patient's cause of disease base reason, all adopts the Chinese herbal medicine of motherland to make up a prescription.Fundamentally patient is treated, improve patient's whole capability and physical vigor, be aided with other massage treatment, the cervical spondylosis patient is reached fully recover with rehabilitation.This medicine is nontoxic simultaneously, no any pair of effect.
Below in conjunction with prescription embodiment is elaborated:
Embodiment 1: to the nerve root cervical vertebra sickness prescription be: gekko six money hippocampus three money sliced CORNUS CERVIs one or two tortoiseshell one or two turtle shell one or two lily one or two the root of straight ladybell one or two root of herbaceous peony, one or two fruit of Chinese magnoliavine, one or two tuber of dwarf lilyturf one or two sun-dried ginseng three money are given birth to and to be steep in wine after the stiff silkworm three money leech of full worm three money of two liang of centipede eight money of the Radix Astragali one or two root bark of tree peony, one or two radix paeoniae rubrathe, the one or two long-noded pit viper three money worms three money arisaema cum bile three money aconiti preparata,radixs three money radix aconiti agrestis five money Semen Strychnis five money notopterygium roots five money roots of kudzu vine five money Jehol Ligusticum Rhizomes three money Rhododendron molles three money dried immature fruit of citron oranges one or two rhubarb six money felworts one or two root of large-flowered skullcap one or two is all pulverized or make pill administration by present pharmaceutical technology (tcd).
Embodiment 2 tremulous pulse myelopathy prescriptions are:
Embodiment 1 except that Radix Et Rhizoma Rhei, Radix Gentianae, Radix Scutellariae do not have, other all identical other interpolation Pericarpium Citri Reticulatae one or two, Radix Bupleuri five money, Concha Haliotidis one or two, SHENGLONGMU one or two, Radix Achyranthis Bidentatae five money, Herba Pogostemonis one or two.Steep in wine after the pulverizing or make pill by existing Chinese medicine processing technology and take.
Claims (1)
1, a kind of treatment cervical spondylosis medicine is characterized in that it is to be made by the raw material of following percentage by weight number: Gecko: 2-3%; Hippocampus: 0.8-2%; Cornu Cervi: 3-5%; Carapax et Plastrum Testudinis: 3-5%; Carapax Trionycis: 3-5%; Bulbus Lilii: 3-5%; Radix Adenophorae (Radix Glehniae): 3-5%; Radix Ophiopogonis: 3-5%; The Radix Paeoniae Alba: 3-5%; Fructus Schisandrae Chinensis: 3-5%; Radix Ginseng: 0.8-2%; Radix Astragali: 3-5%; Cortex Moutan: 3-5%; Radix Paeoniae Rubra: 3-5%; Agkistrodon: 8-10%; Scolopendra: 2-4%; Scorpio: 0.8-2%; Bombyx Batryticatus: 0.8-2%; Hirudo: 0.8-2 Macrophylla; Rhizoma Et Radix Notopterygii: 1-3%; worm: 0.8-2%; Arisaema Cum Bile: 0.8-2%; Radix Aconiti Preparata: 1-3%; Radix Aconiti Kusnezoffii: 1-3%; Semen Strychni: 1-3%; Radix Puerariae: 1-3%; Rhizoma Ligustici: 0.8-2%; Flos Rhododendri Mollis: 0.8-2%; The Fructus Aurantii Immaturus remainder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97109245A CN1062172C (en) | 1997-09-16 | 1997-09-16 | Medicine for treating cervical spondylopathy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97109245A CN1062172C (en) | 1997-09-16 | 1997-09-16 | Medicine for treating cervical spondylopathy |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1176813A CN1176813A (en) | 1998-03-25 |
CN1062172C true CN1062172C (en) | 2001-02-21 |
Family
ID=5171054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97109245A Expired - Fee Related CN1062172C (en) | 1997-09-16 | 1997-09-16 | Medicine for treating cervical spondylopathy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1062172C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100339095C (en) * | 2005-08-25 | 2007-09-26 | 贺拴友 | Cervical spondylosis treating Chinese medicine composition |
CN104435882A (en) * | 2014-11-25 | 2015-03-25 | 四川金堂海纳生物医药技术研究所 | Traditional Chinese medicine decoction for treating cervical vertebra syndrome and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106039045A (en) * | 2016-06-23 | 2016-10-26 | 孙丰卿 | Traditional Chinese medicine compound for treating cervical spondylosis and preparation method for preparation |
-
1997
- 1997-09-16 CN CN97109245A patent/CN1062172C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
《山东中医杂志》1994年第13卷第6期 1994.1.1 郑延平等,中西医结合治疗颈椎病44例 * |
《山东中医杂志》1994年第13卷第6期 1994.1.1 郑延平等,中西医结合治疗颈椎病44例;《陕西中医》1990年第11卷第3期 1990.1.1 杨笃权等舒颈汤治疗颈椎病68例 * |
《陕西中医》1990年第11卷第3期 1990.1.1 杨笃权等舒颈汤治疗颈椎病68例 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100339095C (en) * | 2005-08-25 | 2007-09-26 | 贺拴友 | Cervical spondylosis treating Chinese medicine composition |
CN104435882A (en) * | 2014-11-25 | 2015-03-25 | 四川金堂海纳生物医药技术研究所 | Traditional Chinese medicine decoction for treating cervical vertebra syndrome and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1176813A (en) | 1998-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102078510B (en) | Chinese medicinal composition for treating coronary heart disease | |
CN1327841A (en) | Medicine for treating rheumatoid arthritis | |
CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
CN1062157C (en) | Hepatitis B curing toxin-dissipating pill | |
CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
CN1150928C (en) | Medicine for curing cancers and its preparation method | |
CN101780223B (en) | Traditional Chinese medicine with integral coordination function for treating ischemic cerebrovascular disease | |
CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
CN1181959A (en) | Yin nourishing bolus for curing women's blood deficiency | |
CN102614442A (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
CN104000890B (en) | Traditional Chinese medicine for harmonizing liver and spleen, dispelling wind and eliminating dampness and nourishing blood and stopping throat pains | |
CN1062172C (en) | Medicine for treating cervical spondylopathy | |
CN1376495A (en) | Chinese medicine for treating diabetes and its complication | |
CN101703645B (en) | Chinese medicinal composition for treating cervical vertebra hyperosteogeny | |
CN102600414B (en) | Chinese medicinal composition for treating cervical spondylosis | |
CN1052914C (en) | Suyuwan pill for curing leucoderma | |
CN1183986A (en) | Chinese medicine Pingguxiaociwan for curing Bi-syndrome | |
CN1022165C (en) | Preparation and process of oral medicinal liquid for recuperating blood vessels | |
CN1313120C (en) | Application of ciliate bugle herb piece in preparing medicine for treating scapulohumeral periarthritis | |
CN1090182A (en) | The vasculitic Chinese medicine of a kind of treatment | |
CN107551182A (en) | A kind of Chinese traditional compound medicine for being used to treat hepatic disorder | |
CN100435833C (en) | Medicine for treating Bi syndrome and method for preparing same | |
CN101579458A (en) | Traditional Chinese medicine for treating infant susceptibility | |
CN1352979A (en) | Chinese medicine for replenishing vital energy and promoting blood circulation | |
CN104984162A (en) | Traditional Chinese medicine preparation with effects of dampness dispelling and collateral dredging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |